Scientists have developed an innovative tool, ImmunIC, for accurately identifying and classifying immune cells from single-cell RNA sequencing data. This development, which emerged from an analysis of 66 independent single-cell RNA sequencing studies, holds significant implications for the understanding of disease-specific immune signatures and identifying therapeutic targets.
Single-cell RNA sequencing is an essential tool in immune profiling, enabling researchers to explore the transcriptomic landscape of thousands of individual cells. This method has facilitated the identification of specific immune cells as disease markers and offered potential therapeutic target genes of disease-associated immune cells. However, reliable cell-type classification, a requirement for high-resolution immune profiling, has been hindered by the heterogeneity of gene expression patterns within a single immune cell type.
That's where ImmunIC comes in. This accurate and automated tool has been designed to overcome the limitations of current classification approaches. Tested with over two million immune cells and half-million non-immune cells, ImmunIC has showcased 98% accuracy in identifying immune cells, notably outperforming existing classifiers.
The team used a machine learning method, Xgboost, to enhance the classification resolution, allowing for differentiation between types of T cells. ImmunIC's robustness was confirmed through its ability to handle a massive amount of diverse immune cells and maintain a minimum of 70% accuracy.
In practical terms, ImmunIC demonstrated significant utility by pinpointing immune cell-type specific differential pathways in cases of severe COVID-19 and healthy controls. This included the identification of functional pathways in macrophages, a type of immune cell, that were upregulated among patients with severe COVID-19.
Despite the impressive accuracy achieved in sorting immune cells into ten distinct categories, researchers noted that further annotation into more specific immune cell types remains challenging. However, with the availability of more data and potential novel marker genes, the Xgboost classifier can be expanded to annotate subcategories of each immune cell, which could enhance resolution for identifying more diverse immune cell types.
ImmunIC offers a time-efficient and accurate approach to categorizing ten immune cell populations from multicellular blood and tissue specimens, all from a single command line. This high level of standardization and reproducibility makes ImmunIC a reliable tool for cell-type-specific immune profiling, opening new possibilities for the discovery of disease-specific immune signatures and therapeutic targets.
Read the original publication in Scientific Reports.
Single-cell RNA sequencing is an essential tool in immune profiling, enabling researchers to explore the transcriptomic landscape of thousands of individual cells. This method has facilitated the identification of specific immune cells as disease markers and offered potential therapeutic target genes of disease-associated immune cells. However, reliable cell-type classification, a requirement for high-resolution immune profiling, has been hindered by the heterogeneity of gene expression patterns within a single immune cell type.
That's where ImmunIC comes in. This accurate and automated tool has been designed to overcome the limitations of current classification approaches. Tested with over two million immune cells and half-million non-immune cells, ImmunIC has showcased 98% accuracy in identifying immune cells, notably outperforming existing classifiers.
The team used a machine learning method, Xgboost, to enhance the classification resolution, allowing for differentiation between types of T cells. ImmunIC's robustness was confirmed through its ability to handle a massive amount of diverse immune cells and maintain a minimum of 70% accuracy.
In practical terms, ImmunIC demonstrated significant utility by pinpointing immune cell-type specific differential pathways in cases of severe COVID-19 and healthy controls. This included the identification of functional pathways in macrophages, a type of immune cell, that were upregulated among patients with severe COVID-19.
Despite the impressive accuracy achieved in sorting immune cells into ten distinct categories, researchers noted that further annotation into more specific immune cell types remains challenging. However, with the availability of more data and potential novel marker genes, the Xgboost classifier can be expanded to annotate subcategories of each immune cell, which could enhance resolution for identifying more diverse immune cell types.
ImmunIC offers a time-efficient and accurate approach to categorizing ten immune cell populations from multicellular blood and tissue specimens, all from a single command line. This high level of standardization and reproducibility makes ImmunIC a reliable tool for cell-type-specific immune profiling, opening new possibilities for the discovery of disease-specific immune signatures and therapeutic targets.
Read the original publication in Scientific Reports.